The major cannabinoid found in cannabis is cannabidiol (CBD). Unlike THC, CBD doesn’t make you “high” and typically doesn’t cause any negative effects. CBD is the second most common cannabinoid in the cannabis plant and is best known for its use as CBD oil.

CBD can help with nauseas (especially for intractable anticipatory nausea), has anti-inflammatory  and analgesic effect, , has anxiolytic and antidepressant effect, anticonvulsant effect, may slow down the development of osteoporosis and cancer cell proliferation, and shows to have neuroprotective effect.

Even TGA announced the CBD could be accessed over the counter as a pharmacist only medicines, There are currently no TGA approved products on the Australian Register of Therapeutic Goods (ARTG) that meet the Schedule 3 criteria.

The decision was made following an earlier TGA safety review of low dose CBD which indicated that the known adverse events of CBD at low doses were not serious.

Some of sponsoring companies lodged an application to the TGA for inclusion of Schedule 3 CBD preparations on the ARTG. We are expecting OTC CBD probably by the end of 2022.